Pfizer Inc. - SWOT, Strategy and Corporate Finance Report
Published: June 2013 · Publisher: MarketLine
Pfizer Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc.
- Description
- Table of Contents
- Ask a Question
Pfizer Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360˚ view of the company.
Features:
- Detailed information on Pfizer Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Pfizer Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Pfizer Inc. including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Pfizer Inc.
- Intelligence on Pfizer Inc.nv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Pfizer Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Pfizer (or ‘the company’) is the world's largest biopharmaceutical company. Its portfolio includes human biologic, small molecule medicines, vaccines and consumer products. The company operates in more than 150 countries. It is headquartered in New York City, New York and employed 91,500 people as of December 31, 2012. The company recorded revenues of $58,986 million during the financial year ended December 2012 (FY2012), a decrease of 9.6% over FY2011. The operating profit of the company was $12,080 million in FY2012, a decrease of 1.8% over FY2011. The net profit was $14,570 million in FY2012, an increase of 45.6% over 2011.
Reasons to Purchase:
- Gain understanding of Pfizer Inc. and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Pfizer Inc. as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Pfizer Inc.’s business structure, strategy and prospects
Features:
- Detailed information on Pfizer Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Pfizer Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Pfizer Inc. including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Pfizer Inc.
- Intelligence on Pfizer Inc.nv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Pfizer Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Pfizer (or ‘the company’) is the world's largest biopharmaceutical company. Its portfolio includes human biologic, small molecule medicines, vaccines and consumer products. The company operates in more than 150 countries. It is headquartered in New York City, New York and employed 91,500 people as of December 31, 2012. The company recorded revenues of $58,986 million during the financial year ended December 2012 (FY2012), a decrease of 9.6% over FY2011. The operating profit of the company was $12,080 million in FY2012, a decrease of 1.8% over FY2011. The net profit was $14,570 million in FY2012, an increase of 45.6% over 2011.
Reasons to Purchase:
- Gain understanding of Pfizer Inc. and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Pfizer Inc. as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Pfizer Inc.’s business structure, strategy and prospects
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
Company Snapshot
Pfizer Inc.: Company Overview
Pfizer Inc.: Overview and Key Facts
Pfizer Inc.: Overview
Pfizer Inc.: Key Facts
Pfizer Inc.: Key Employees
Pfizer Inc.: Key Employee Biographies
Pfizer Inc.: Major Products and Services
Pfizer Inc.: Company History
Pfizer Inc.: Management Statement
Pfizer Inc.: Locations and Subsidiaries
Pfizer Inc.: Key Competitors
Pfizer Inc.: Company Analysis
Pfizer Inc.: Business Description
Pfizer Inc.: SWOT Analysis
Pfizer Inc.: SWOT Overview
Pfizer Inc.: Strengths
Pfizer Inc.: Weaknesses
Pfizer Inc.: Opportunities
Pfizer Inc.: Threats
Pfizer Inc.: Financial Analysis
Pfizer Inc.: Financial Overview
Pfizer Inc.: Five Year Company Financials
Pfizer Inc.: Key Income Statement Data
Pfizer Inc.: Key Balance Sheet Data
Pfizer Inc.: Key Cash Flow Data
Pfizer Inc.: Key Market Data
Pfizer Inc.: Valuation Ratios
Pfizer Inc.: Profitability Ratios
Pfizer Inc.: Management Efficiency Ratios
Pfizer Inc.: Financial Strength Ratios
Pfizer Inc.: Operational Efficiency Ratios
Pfizer Inc.: Others
Pfizer Inc.: Corporate Financial Deals Activity
Pfizer Inc.: Financial Deals Overview
Pfizer Inc.: Targets and Partners
Pfizer Inc.: Top Deals 2009 - 2013YTD*
Pfizer Inc.: Advisors
Pfizer Inc.: Top Legal Advisors
Pfizer Inc.: Top Financial Advisors
Pfizer Inc.: Mergers and Acquisitions
Pfizer Inc.: Corporate Venturing
Pfizer Inc.: Capital Raising
Pfizer Inc.: Partnership
Pfizer Inc.: Divestments
Pfizer Inc.: Recent Developments
Pfizer Inc.: News and Events Summary
Pfizer Inc.: Business Expansion
Pfizer Inc.: Contracts
Pfizer Inc.: Financial Deals
Pfizer Inc.: Red Flags/DistressSignals
Pfizer Inc.: Regulatory and Legal Events
Pfizer Inc.: Research & Development
Appendix
Contact Us
Methodology
Definitions
List of Tables
Table 1: Pfizer Inc.: Key Facts
Table 2: Pfizer Inc.: Key Employees
Table 4: Pfizer Inc.: Key Competitors
Table 5: Pfizer Inc.: Key Income Statement Data
Table 6: Pfizer Inc.: Key Balance Sheet Data
Table 7: Pfizer Inc.: Key Cash Flow Data
Table 8: Pfizer Inc.: Key Market Data
Table 9: Pfizer Inc.: Key Growth Ratios
Table 10: Pfizer Inc.: Valuation Ratios
Table 11: Pfizer Inc.: Profitability Ratios
Table 12: Pfizer Inc.: Management Efficiency Ratios
Table 13: Pfizer Inc.: Financial Strength Ratios
Table 14: Pfizer Inc.: Operational Efficiency Ratios
Table 15: Pfizer Inc.: Others
Table 16: Pfizer Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 17: Pfizer Inc.: M&A Activity by Geography (TTM*)
Table 18: Pfizer Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 19: Pfizer Inc.: M&A Average Deal Size - Value (US$m)
Table 20: Pfizer Inc.: Targets and Partners
Table 21: Pfizer Inc.: Top Deals 2009 - 2013YTD*
Table 22: Pfizer Inc.: Legal Advisor Ranking by Value (US$m)
Table 23: Pfizer Inc.: Financial Advisor Ranking by Value (US$m)
Table 24: Pfizer Inc.: M&A Volume and Value Trend (2009 - YTD*2013)
Table 25: Pfizer Inc.: M&A Activity by Geography (2009 - YTD*2013)
Table 26: Pfizer Inc.: Corporate Venturing Volume and Value Trend (2009 - YTD*2013)
Table 27: Pfizer Inc.: Corporate Venturing by Geography (2009 - YTD*2013)
Table 28: Pfizer Inc.: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Table 29: Pfizer Inc.: Capital Raising by Deal Type (2009 - YTD*2013)
Table 30: Pfizer Inc.: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 31: Pfizer Inc.: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 32: Pfizer Inc.: Divestments Volume and Value Trend (2009 - YTD*2013)
Table 33: Pfizer Inc.: Divestments by Geography (2009 - YTD*2013)
Table 34: Pfizer Inc.: News and Events Summary
Table 35: Pfizer Inc.: Business Expansion
Table 36: Pfizer Inc.: Contracts
Table 37: Pfizer Inc.: Financial Deals
Table 38: Pfizer Inc.: Red Flags/DistressSignals
Table 39: Pfizer Inc.: Regulatory and Legal Events
Table 40: Pfizer Inc.: Research & Development
List of Figures
Figure 1: Pfizer Inc.: Revenue to Net Income (2007-2011)
Figure 2: Pfizer Inc.: Revenue/Employee to Net Income/Employee (2007-2011)
Figure 3: Pfizer Inc.: Current Assets to Current Liabilities (2007-2011)
Figure 4: Pfizer Inc.: Assets, Liabilities to Total Equity (2007-2011)
Figure 5: Pfizer Inc.: Free Cash Flow to Cash from Operating Activities (2007-2011)
Figure 6: Pfizer Inc.: Net Change in Cash (2007-2011)
Figure 7: Pfizer Inc.: Market Capitalization to Year-end Share Price (2007-2011)
Figure 8: Pfizer Inc.: Enterprise Value (2007-2011)
Figure 9: Pfizer Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 10: Pfizer Inc.: M&A Activity by Geography (TTM*)
Figure 11: Pfizer Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Figure 12: Pfizer Inc.: M&A Average Deal Size - Value (US$m)
Figure 13: Pfizer Inc.: M&A Volume and Value Trend (2009 - YTD*2013)
Figure 14: Pfizer Inc.: M&A Activity by Geography (2009 - YTD*2013)
Figure 15: Pfizer Inc.: Corporate Venturing Volume and Value Trend (2009 - YTD*2013)
Figure 16: Pfizer Inc.: Corporate Venturing by Geography (2009 - YTD*2013)
Figure 17: Pfizer Inc.: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Figure 18: Pfizer Inc.: Capital Raising by Deal Type (2009 - YTD*2013)
Figure 19: Pfizer Inc.: Partnership Volume and Value Trend (2009 - YTD*2013)
Figure 20: Pfizer Inc.: Partnership Trend by Deal Type (2009 - YTD*2013)
Figure 21: Pfizer Inc.: Divestments Volume and Value Trend (2009 - YTD*2013)
Figure 22: Pfizer Inc.: Divestments by Geography (2009 - YTD*2013)
Pfizer Inc.: Company Overview
Pfizer Inc.: Overview and Key Facts
Pfizer Inc.: Overview
Pfizer Inc.: Key Facts
Pfizer Inc.: Key Employees
Pfizer Inc.: Key Employee Biographies
Pfizer Inc.: Major Products and Services
Pfizer Inc.: Company History
Pfizer Inc.: Management Statement
Pfizer Inc.: Locations and Subsidiaries
Pfizer Inc.: Key Competitors
Pfizer Inc.: Company Analysis
Pfizer Inc.: Business Description
Pfizer Inc.: SWOT Analysis
Pfizer Inc.: SWOT Overview
Pfizer Inc.: Strengths
Pfizer Inc.: Weaknesses
Pfizer Inc.: Opportunities
Pfizer Inc.: Threats
Pfizer Inc.: Financial Analysis
Pfizer Inc.: Financial Overview
Pfizer Inc.: Five Year Company Financials
Pfizer Inc.: Key Income Statement Data
Pfizer Inc.: Key Balance Sheet Data
Pfizer Inc.: Key Cash Flow Data
Pfizer Inc.: Key Market Data
Pfizer Inc.: Valuation Ratios
Pfizer Inc.: Profitability Ratios
Pfizer Inc.: Management Efficiency Ratios
Pfizer Inc.: Financial Strength Ratios
Pfizer Inc.: Operational Efficiency Ratios
Pfizer Inc.: Others
Pfizer Inc.: Corporate Financial Deals Activity
Pfizer Inc.: Financial Deals Overview
Pfizer Inc.: Targets and Partners
Pfizer Inc.: Top Deals 2009 - 2013YTD*
Pfizer Inc.: Advisors
Pfizer Inc.: Top Legal Advisors
Pfizer Inc.: Top Financial Advisors
Pfizer Inc.: Mergers and Acquisitions
Pfizer Inc.: Corporate Venturing
Pfizer Inc.: Capital Raising
Pfizer Inc.: Partnership
Pfizer Inc.: Divestments
Pfizer Inc.: Recent Developments
Pfizer Inc.: News and Events Summary
Pfizer Inc.: Business Expansion
Pfizer Inc.: Contracts
Pfizer Inc.: Financial Deals
Pfizer Inc.: Red Flags/DistressSignals
Pfizer Inc.: Regulatory and Legal Events
Pfizer Inc.: Research & Development
Appendix
Contact Us
Methodology
Definitions
List of Tables
Table 1: Pfizer Inc.: Key Facts
Table 2: Pfizer Inc.: Key Employees
Table 4: Pfizer Inc.: Key Competitors
Table 5: Pfizer Inc.: Key Income Statement Data
Table 6: Pfizer Inc.: Key Balance Sheet Data
Table 7: Pfizer Inc.: Key Cash Flow Data
Table 8: Pfizer Inc.: Key Market Data
Table 9: Pfizer Inc.: Key Growth Ratios
Table 10: Pfizer Inc.: Valuation Ratios
Table 11: Pfizer Inc.: Profitability Ratios
Table 12: Pfizer Inc.: Management Efficiency Ratios
Table 13: Pfizer Inc.: Financial Strength Ratios
Table 14: Pfizer Inc.: Operational Efficiency Ratios
Table 15: Pfizer Inc.: Others
Table 16: Pfizer Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 17: Pfizer Inc.: M&A Activity by Geography (TTM*)
Table 18: Pfizer Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 19: Pfizer Inc.: M&A Average Deal Size - Value (US$m)
Table 20: Pfizer Inc.: Targets and Partners
Table 21: Pfizer Inc.: Top Deals 2009 - 2013YTD*
Table 22: Pfizer Inc.: Legal Advisor Ranking by Value (US$m)
Table 23: Pfizer Inc.: Financial Advisor Ranking by Value (US$m)
Table 24: Pfizer Inc.: M&A Volume and Value Trend (2009 - YTD*2013)
Table 25: Pfizer Inc.: M&A Activity by Geography (2009 - YTD*2013)
Table 26: Pfizer Inc.: Corporate Venturing Volume and Value Trend (2009 - YTD*2013)
Table 27: Pfizer Inc.: Corporate Venturing by Geography (2009 - YTD*2013)
Table 28: Pfizer Inc.: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Table 29: Pfizer Inc.: Capital Raising by Deal Type (2009 - YTD*2013)
Table 30: Pfizer Inc.: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 31: Pfizer Inc.: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 32: Pfizer Inc.: Divestments Volume and Value Trend (2009 - YTD*2013)
Table 33: Pfizer Inc.: Divestments by Geography (2009 - YTD*2013)
Table 34: Pfizer Inc.: News and Events Summary
Table 35: Pfizer Inc.: Business Expansion
Table 36: Pfizer Inc.: Contracts
Table 37: Pfizer Inc.: Financial Deals
Table 38: Pfizer Inc.: Red Flags/DistressSignals
Table 39: Pfizer Inc.: Regulatory and Legal Events
Table 40: Pfizer Inc.: Research & Development
List of Figures
Figure 1: Pfizer Inc.: Revenue to Net Income (2007-2011)
Figure 2: Pfizer Inc.: Revenue/Employee to Net Income/Employee (2007-2011)
Figure 3: Pfizer Inc.: Current Assets to Current Liabilities (2007-2011)
Figure 4: Pfizer Inc.: Assets, Liabilities to Total Equity (2007-2011)
Figure 5: Pfizer Inc.: Free Cash Flow to Cash from Operating Activities (2007-2011)
Figure 6: Pfizer Inc.: Net Change in Cash (2007-2011)
Figure 7: Pfizer Inc.: Market Capitalization to Year-end Share Price (2007-2011)
Figure 8: Pfizer Inc.: Enterprise Value (2007-2011)
Figure 9: Pfizer Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 10: Pfizer Inc.: M&A Activity by Geography (TTM*)
Figure 11: Pfizer Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Figure 12: Pfizer Inc.: M&A Average Deal Size - Value (US$m)
Figure 13: Pfizer Inc.: M&A Volume and Value Trend (2009 - YTD*2013)
Figure 14: Pfizer Inc.: M&A Activity by Geography (2009 - YTD*2013)
Figure 15: Pfizer Inc.: Corporate Venturing Volume and Value Trend (2009 - YTD*2013)
Figure 16: Pfizer Inc.: Corporate Venturing by Geography (2009 - YTD*2013)
Figure 17: Pfizer Inc.: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Figure 18: Pfizer Inc.: Capital Raising by Deal Type (2009 - YTD*2013)
Figure 19: Pfizer Inc.: Partnership Volume and Value Trend (2009 - YTD*2013)
Figure 20: Pfizer Inc.: Partnership Trend by Deal Type (2009 - YTD*2013)
Figure 21: Pfizer Inc.: Divestments Volume and Value Trend (2009 - YTD*2013)
Figure 22: Pfizer Inc.: Divestments by Geography (2009 - YTD*2013)
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.